As of Oct 26, 2026: Savara (SVRA) has a PDUFA date for Molgramostim on Nov 22, 2026, in 27 days. Its Quality Score is -4. Scores as of 8:36 PM ET, 15 minutes behind.

SVRA FDA decision on Molgramostim

Savara · PDUFA date

PDUFA dateNov 22in 27 days Quality Score-4Poor

Cash runway6quarters of cash

What the company said

“during their review constituted a major amendment to the BLA, resulting in a three-month extension of the Prescription Drug User Fee Act ("PDUFA") target action date to November 22, 2026.”

PDUFA date, Nov 22, 2026. As Savara stated in its 10-Q of Aug 11, 2026 (the filing).

A PDUFA date is the day the FDA has said it aims to decide on a drug. The FDA can decide earlier, or extend its review, often by three months.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Get an alert before SVRA's FDA date

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

How SVRA's stock moved on its past FDA days, for Pro members. Pro members also see whether its cash lasts past Nov 22, and the members' FDA calendar with filters and optional alerts.

More on SVRA and the FDA calendar

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

The FDA calendar.